Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00165269 · ClinicalTrials.gov registry record · Phase 2
Mantle Irradiation for Hodgkin's Disease
A Phase 2 study of Hodgkin's Disease, sponsored by Dana-Farber Cancer Institute.
- Completed
- Registry status
- Phase 2
- Development phase
- 100
- Enrollment target
- 2
- Study locations
NCT00165269: Completed Phase 2 study of Hodgkin's Disease, sponsored by Dana-Farber Cancer Institute.
NCT00165269 is a Phase 2 study of Hodgkin's Disease that has completed, run by Dana-Farber Cancer Institute. The registered enrollment target is 100 participants, below the 233-participant average among 20 other Hodgkin's Disease trials with a reported enrollment target (57% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00165269, a Phase 2 study of Hodgkin's Disease, has completed, sponsored by Dana-Farber Cancer Institute.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 100 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this study it to evaluate the effectiveness of radiation therapy limited to above the diaphragm in patients with pathological stage IA-IIA Hodgkin's disease.
Conditions Studied
Interventions
- PROCEDURE Mantle irradiation
Study Locations (2)
Massachusetts
- Dana-Farber Cancer Center - Boston
- Massachusetts General Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 1992-05 |
| Est. Completion | 2008-02 |
| Phase | Phase 2 |
What the finished NCT00165269 record still lists
NCT00165269 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 233-participant average among 20 other Hodgkin's Disease trials with a reported enrollment target (57% lower).
The record links to 1 condition, with Hodgkin's Disease appearing as the primary indexed condition, and to 1 intervention - of which Mantle irradiation is the first listed.
NCT00165269 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT00165269 about?
NCT00165269 is a clinical study titled "Mantle Irradiation for Hodgkin's Disease". The purpose of this study it to evaluate the effectiveness of radiation therapy limited to above the diaphragm in patients with pathological stage IA-IIA Hodgkin's disease.
What is the current status of trial NCT00165269?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 100 participants. The study started on 1992-05. Estimated completion is 2008-02.
What conditions does trial NCT00165269 study?
This clinical trial studies the following conditions: Hodgkin's Disease.
What interventions are being tested in trial NCT00165269?
The interventions under investigation include: Mantle irradiation (PROCEDURE).
Who is sponsoring clinical trial NCT00165269?
This trial is sponsored by Dana-Farber Cancer Institute, which has 781 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00165269 being conducted?
This trial has 2 study locations across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hodgkin's Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00165269's enrollment target sits among peer trials
100 7th of 20 higher than 14 of 20 other Hodgkin's Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hodgkin's Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Sirolimus With Tacrolimus for Graft-vs-Host Disease Prophylaxis After Un-Related Stem Cell Transplantation
COMPLETED · Phase 2
-
Amifostine for Head and Neck Irradiation in Lymphoma
COMPLETED · Phase 2
-
A Study to Evaluate the Safety, Pharmacokinetics, and Hematopoietic Stem Cell Mobilization of TG-0054 Alone or in Combination With G-CSF in Patients With Multiple Myeloma, Non-Hodgkin Lymphoma or Hodgkin Disease
COMPLETED · Phase 2
-
Allogeneic Transplantation From Related Haploidentical Donors
COMPLETED · Phase 2
-
Efficacy Study of T Cell Depleted Allogeneic Non-myeloablative Stem Cell Transplant
COMPLETED · Phase 2
-
A Randomized Study of EPOCH II Versus EPOCH II and Immunotherapy in Lymphomas
COMPLETED · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia